INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-08-19 pm EDT
75.05 USD   -1.51%
08/17INSIDER SELL : Inari Medical
MT
08/17INSIDER SELL : Inari Medical
MT
08/04INSIDER SELL : Inari Medical
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Piper Sandler Starts Inari Medical at Overweight With $100 Price Target

06/21/2022 | 05:16am EDT


© MT Newswires 2022
All news about INARI MEDICAL, INC.
08/17INSIDER SELL : Inari Medical
MT
08/17INSIDER SELL : Inari Medical
MT
08/04INSIDER SELL : Inari Medical
MT
08/04INARI MEDICAL : Profile August 2022
PU
08/04INARI MEDICAL : Presentation August 2022
PU
08/04Inari Medical Promotes COO Drew Hykes to CEO
MT
08/03INARI MEDICAL : Announces Leadership Succession Plan - Form 8-K
PU
08/03INARI MEDICAL, INC. : Change in Directors or Principal Officers, Other Events, Financial S..
AQ
08/03INSIDER SELL : Inari Medical
MT
08/03TRANSCRIPT : Inari Medical, Inc., Q2 2022 Earnings Call, Aug 03, 2022
CI
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 368 M - -
Net income 2022 -38,2 M - -
Net cash 2022 315 M - -
P/E ratio 2022 -105x
Yield 2022 -
Capitalization 4 068 M 4 068 M -
EV / Sales 2022 10,2x
EV / Sales 2023 8,50x
Nbr of Employees 800
Free-Float 85,0%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 76,20 $
Average target price 102,50 $
Spread / Average Target 34,5%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-16.51%4 068
SHOCKWAVE MEDICAL, INC.66.42%10 662
MASIMO CORPORATION-45.38%8 401
NOVOCURE LIMITED6.57%8 380
PENUMBRA, INC.-41.81%6 335
GETINGE AB-44.42%5 724